Sureau C - Search Results

1

HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.

Alfaiate D, Lucifora J, Abeywickrama-Samarakoon N, Michelet M, Testoni B, Cortay JC, Sureau C, Zoulim F, Dény P, Durantel D. Alfaiate D, et al. Among authors: sureau c. Antiviral Res. 2016 Dec;136:19-31. doi: 10.1016/j.antiviral.2016.10.006. Epub 2016 Oct 19. Antiviral Res. 2016. PMID: 27771387 Free article.

2

The role of the HBV envelope proteins in the HDV replication cycle.

Sureau C. Sureau C. Curr Top Microbiol Immunol. 2006;307:113-31. doi: 10.1007/3-540-29802-9_6. Curr Top Microbiol Immunol. 2006. PMID: 16903223 Review.

3

Myristoylation signal transfer from the large to the middle or the small HBV envelope protein leads to a loss of HDV particles infectivity.

Abou-Jaoudé G, Molina S, Maurel P, Sureau C. Abou-Jaoudé G, et al. Among authors: sureau c. Virology. 2007 Aug 15;365(1):204-9. doi: 10.1016/j.virol.2007.03.030. Epub 2007 Apr 25. Virology. 2007. PMID: 17462692 Free article.

4

In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.

Villet S, Billioud G, Pichoud C, Lucifora J, Hantz O, Sureau C, Dény P, Zoulim F. Villet S, et al. Among authors: sureau c. Gastroenterology. 2009 Jan;136(1):168-176.e2. doi: 10.1053/j.gastro.2008.09.068. Epub 2008 Oct 7. Gastroenterology. 2009. PMID: 18996386

5

The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model.

Sureau C. Sureau C. Methods Mol Biol. 2010;640:463-73. doi: 10.1007/978-1-60761-688-7_25. Methods Mol Biol. 2010. PMID: 20645068

6

Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle.

Blanchet M, Sureau C, Labonté P. Blanchet M, et al. Among authors: sureau c. Antiviral Res. 2014 Jun;106:111-5. doi: 10.1016/j.antiviral.2014.03.017. Epub 2014 Apr 6. Antiviral Res. 2014. PMID: 24717262

7

SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection.

Blanchet M, Sureau C, Guévin C, Seidah NG, Labonté P. Blanchet M, et al. Among authors: sureau c. Antiviral Res. 2015 Mar;115:94-104. doi: 10.1016/j.antiviral.2014.12.017. Epub 2015 Jan 5. Antiviral Res. 2015. PMID: 25573299

8

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B, Cosset FL, Strick-Marchand H, Trépo C, Kao JH, Carrat F, Lacombe K, Schinazi RF, Barré-Sinoussi F, Delfraissy JF, Zoulim F. Zeisel MB, et al. Among authors: sureau c. Gut. 2015 Aug;64(8):1314-26. doi: 10.1136/gutjnl-2014-308943. Epub 2015 Feb 10. Gut. 2015. PMID: 25670809 Review.

9

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.

Verrier ER, Colpitts CC, Bach C, Heydmann L, Weiss A, Renaud M, Durand SC, Habersetzer F, Durantel D, Abou-Jaoudé G, López Ledesma MM, Felmlee DJ, Soumillon M, Croonenborghs T, Pochet N, Nassal M, Schuster C, Brino L, Sureau C, Zeisel MB, Baumert TF. Verrier ER, et al. Among authors: sureau c. Hepatology. 2016 Jan;63(1):35-48. doi: 10.1002/hep.28013. Epub 2015 Oct 6. Hepatology. 2016. PMID: 26224662

10

The hepatitis delta virus: Replication and pathogenesis.

Sureau C, Negro F. Sureau C, et al. J Hepatol. 2016 Apr;64(1 Suppl):S102-S116. doi: 10.1016/j.jhep.2016.02.013. J Hepatol. 2016. PMID: 27084031 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page